Assembly Biosciences Inc.

09/23/2024 | Press release | Distributed by Public on 09/23/2024 06:31

Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long Acting Helicase Primase Inhibitor Candidate ABI 5366